Adjuvant setting
What will happen?
•
Ongoing adjuvant studies with anti-PD1/anti-PDL1 strategies
Different compounds, large sample size
Optimism for positive results in the adjuvant setting
o
Heterogeneity in patients included (staging, different surgery
standards)
o
Long follow-up needed
o
How will treatments at recurrence affect study outcomes
